Condition: Ulcerative Colitis · Sponsor: National University of Malaysia
Probiotics are one of the adjunctive treatments that have been extensively explored for Ulcerative colitis (UC) disease management. Probiotics, a group of beneficial bacteria, can bring various health benefits when adequately supplied to the body, especially for gut wellness. In particular, for UC patients, gut dysbiosis is one of the contributing factors in their pathogenesis. Thus, the supplementation of probiotics in combination with standard treatment can potentially help in relieving symptoms as well as promoting mucosal healing for long-term remission.
This description comes directly from the study's public registry record.
Norfilza M Mokhtar, MD, MMedSci, PhD · +60391458610 · norfilza@ppukm.ukm.edu.my
Raja Affendi Raja Ali, MBBChBaO,MD,MMedSci,MBA,CCST · +60391455202 · draffendi@ppukm.ukm.edu.my
Always discuss trial participation with your own doctor first.
| Hospital Canselor Tuanku Muhriz UKM | Cheras, Kuala Lumpur, Malaysia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06595719